April 14, 2026

Virginia governor signs ADA-supported workforce bills into law

Virginia Governor Abigail Spanberger has signed into law two dental workforce-related measures backed by both the VDA and the ADA.

ADA News

April 13, 2026

Electroacupuncture May Relieve Cognitive, Psychological Symptoms in Breast Cancer Survivors in Pilot Study

Electroacupuncture may alleviate some persistent neuropsychiatric symptoms experienced by breast cancer survivors, including psychological distress and cognitive impairment, according to the results o...

The ASCO Post

April 11, 2026

The Importance of Treating OSD and Lid Margin Disease Preoperatively

Marjan Farid, MD, discusses her ASCRS Cornea Day presentation on preoperatively treating DED and OSD.

Ophthalmology Management

April 08, 2026

Optimizing the Ocular Surface Before and After Cataract Surgery

The role of perfluorohexyloctane in dry eye management

The Ophthalmologist

April 08, 2026

AAD Issues Pediatric Atopic Dermatitis Guidelines

Two companion guidelines provide 41 evidence-based recommendations on treatment and prevention, along with 29 statements on comorbidity associations in patients under 18

Conexiant

April 07, 2026

Maryland orders Cigna to stop automatic downcoding, issues $80,000 fine 

Maryland’s Insurance Administration has fined health insurance company Cigna $80,000.

ADA News

April 02, 2026

ADA raises concerns about CMS CRUSH initiative proposals affecting dentistry

The ADA raises critical concerns over the implications of CMS's CRUSH initiative on dental practices, highlighting potential challenges in fraud reduction and patient access.

ADA News

April 01, 2026

Problem-Solving

Explore a new classification system for halitosis that promises improved diagnosis and treatment strategies, alongside critical insights on penicillin allergy in dentistry.

Compendium

April 01, 2026

EULAR Updates Behçet’s Syndrome Recommendations

EULAR releases updated recommendations supporting earlier biologic use in patients with eye, vascular, and nervous system involvement

Conexiant

April 01, 2026

Evolocumab Reduced CV Events in Diabetes

Subgroup analysis of the VESALIUS-CV trial supports earlier intensive lipid lowering

Conexiant